An AI Tool to Identify Cardiovascular Disease Risk Before Symptoms Appear has been Approved by the FDA
The FDA approved a novel AI tool that can identify underlying structural heart disease before symptoms appear. · The first artificial intelligence tool to identify hidden structural heart disease during standard ECGs was approved by the FDA. · EchoNext is a cardiac screening designed to detect underlying disease before symptoms arise. · In a 45-year-old man who eventually underwent a successful heart transplant, the new technique is credited with identifying serious, undetected heart failure. There is currently no early-detection test for cardiovascular disease, which is the world's biggest cause of mortality. A new tool for early detection of heart disease was approved by the Food and Drug Administration (FDA) on June 22. According to its manufacturer, Pathway Labs, EchoNext is an artificial intelligence tool that analyses a standard elec...